About Celadon Pharmaceuticals
Celadon Pharmaceuticals is a company based in London (United Kingdom) founded in 2018. Celadon Pharmaceuticals offers products and services including GMP Cannabis API and Cannabis-based Medicines. Celadon Pharmaceuticals operates in a competitive market with competitors including Ergomed and TTS Pharma, among others.
- Headquarter London, United Kingdom
- Stage Public
- SectorsHealthcare
- Website celadonpharma.com
- Legal Name Celadon Pharmaceuticals Plc
- Latest Funding Round$2.51M (USD), Post-IPO
Dec 2023
Products & Services of Celadon Pharmaceuticals
Celadon Pharmaceuticals offers a comprehensive portfolio of products and services, including GMP Cannabis API and Cannabis-based Medicines.
Extracted active ingredient for cannabis-based medicines
Treatments for chronic pain and neurological conditions
Funding Insights of Celadon Pharmaceuticals
- Total Rounds 1
- Last Round Post-IPO — $2.51M
- First Round $2.51M
(Dec 2023)
All 1 funding rounds of Celadon Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $2.51M | Post-IPO | – | – | – |
Timeline of Celadon Pharmaceuticals
3 dated milestones of Celadon Pharmaceuticals across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Celadon Pharmaceuticals is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.5M.
Competitors of Celadon Pharmaceuticals
Celadon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ergomed and TTS Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medsource.com | 1997 | Houston, United States | – | – | Full-service CRO operations are focused on oncology and complex trials. | |
| ttspharma.com | 2012 | Liverpool, United Kingdom | $13.94M | 6 | TTS Pharma is engaged in producing high-quality, safe Cannabinoid products. |
Detailed competitors of Celadon Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Celadon Pharmaceuticals
The website of Celadon Pharmaceuticals (celadonpharma.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 21.6% vs previous month
Latest news on Celadon Pharmaceuticals
Complete news archive for Celadon Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Celadon Pharmaceuticals
10 companies that operate in the same segment as Celadon Pharmaceuticals (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 137 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celadon Pharmaceuticals
Celadon Pharmaceuticals was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Celadon Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Celadon Pharmaceuticals was founded in 2018 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, with services centered on clinical trials for cannabis-based products. Support is offered to clients through trial management, regulatory compliance, and data analysis. The company serves the growing cannabis research market, ensuring adherence to UK and international standards for drug development.
Celadon Pharmaceuticals's top competitors include TTS Pharma and Ergomed.
Celadon Pharmaceuticals offers GMP Cannabis API and Cannabis-based Medicines.
Celadon Pharmaceuticals operates through Celadon Pharmaceuticals Plc.